4.3 Article

Prognostic impact of pre- and postoperative tumor markers in patients with intrahepatic cholangiocarcinoma

Journal

SURGERY TODAY
Volume -, Issue -, Pages -

Publisher

SPRINGER
DOI: 10.1007/s00595-023-02715-8

Keywords

Carbohydrate antigen 19-9; Carcinoembryonic antigen; Intrahepatic cholangiocarcinoma; Neoadjuvant therapy; Postoperative

Categories

Ask authors/readers for more resources

The impact of pre- and postoperative tumor markers on the survival of patients with intrahepatic cholangiocarcinoma was assessed in this study. Medical records of 73 patients were reviewed and the levels of carcinoembryonic antigen and carbohydrate antigen 19-9 were assessed. Patient characteristics, clinicopathological factors, and prognostic factors were analyzed.
PurposeThe present study assessed the impact of pre- and postoperative tumor markers on the survival of patients with intrahepatic cholangiocarcinoma.MethodsMedical records of 73 patients with intrahepatic cholangiocarcinoma were reviewed retrospectively. The pre- and postoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels were assessed. Patient characteristics, clinicopathological factors, and prognostic factors were analyzed.ResultsThe median recurrence-free survival and overall survival were 30.0 and 90.9 months, respectively. A multivariate survival analysis revealed that elevated postoperative carbohydrate antigen 19-9 (p = 0.023) was the only independent poor prognostic factor. The median overall survival of patients with normal and elevated postoperative carbohydrate antigen 19-9 levels was 101.4 and 15.7 months (p < 0.001), respectively. Multivariate logistic regression identified elevated preoperative carbohydrate antigen 19-9 as an independent preoperative risk factor for elevated postoperative carbohydrate antigen 19-9. The optimal cutoff value of preoperative carbohydrate antigen 19-9 for predicting elevated postoperative carbohydrate antigen 19-9 was 40 U/mL, with a sensitivity and specificity of 92% and 87%, respectively (area under curve = 0.915).ConclusionsElevated postoperative carbohydrate antigen 19-9 was an independent poor prognostic factor. Preoperative predictors, such as elevated preoperative carbohydrate antigen 19-9, may indicate the need for neoadjuvant therapies to improve the survival.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available